On Monday, Sudarshan Pharma Industries Ltd shares rose 4.64% to ₹32.50. The API manufacturer reported a turnaround net profit of ₹3.96 crore in Q1FY26, up 427.3% YoY, from a ₹1.21 crore net loss. Net sales also grew 46.4%. The company is acquiring land and machinery from Srigen Lifesciences for ₹25.50 crore to expand production.